Resveratrol for Anti-Aging

Research suggests that resveratrol, a polyphenol found in grapes, berries, and peanuts, may counteract several biological mechanisms associated with aging, including oxidative stress, chronic inflammation, cellular senescence, and telomere shortening, with supporting evidence from multiple reviews indicating potential relevance to cardiovascular health, neurodegeneration, and metabolic disease. The available literature consists primarily of narrative and systematic reviews along with preclinical studies in model organisms such as C. elegans and mice, with notably limited high-quality human clinical trial data, meaning the translation of these findings to human aging outcomes remains an open question. Studies indicate that resveratrol's practical utility is complicated by well-documented challenges with bioavailability and chemical stability, and a 2020 review specifically highlights that human trial results have been conflicting, optimal dosing is unclear, and potential adverse effects and drug interactions have not been thoroughly characterized. A 2022 C. elegans study also raised a cautionary note, finding that resveratrol's effects on lifespan and health measures varied substantially by genetic background, reinforcing that anti-aging benefits observed in controlled laboratory settings may not be broadly or consistently reproducible across diverse populations.